Navigation Links
PKG in the On Position Results in Chronic Pain

Richard Ambron from Columbia University in New York City has discovered that chronic pain occurs as a result of hyper-excitable neurons. //

He and his colleagues were studying chronic pain at the molecular and cellular level. Normally at the molecular level a pain stimulus occurs and the neurons becomes excited and begin to send signals to the brain and the individual sense pain but when the stimulus is removed the nerves become dormant and there is no sense of pain. In case of patients suffering from chronic pain the nerves remain the hyper- excitable stage and remains so even if there is a very mild stimulus.

This is because of the enzyme called protein kinase G or PKG. if it is in the on position then the nerves keep sending signals long after the injury that originally caused the pain has healed. Hence drugs should be developed to target this enzyme and shut down the enzyme. It is a new approach to pain relief for the millions suffering from chronic pain. Statistics show that about 48 million Americans suffer from long-lasting pain. Current pain drugs have side effects such as drowsiness and sometimes do not work with certain individuals. The study is done in mice and will be published in the journal Neuroscience.


'"/>




Page: 1

Related medicine news :

1. Sleeping Position Speaks A Lot About The Couples Relationship
2. Vitamin D In Pole Position At Clinical Endocrinologists Meet
3. Two New Anesthesia Positions Promise to Ease Surgery Queue
4. Hormone Deficiency Results In Miscarriage
5. Breast Implants May Interfere With The Interpretation Of Mammogram Results
6. DNA Testing For More Accurate Results
7. Operating on a Beating Heart Yields Better Results For Blocked Heart Arteries
8. Intense Fight Against Polio In India Gets Results
9. Deadly Diarrhoea Vaccine – Trail Results Promising
10. Novartis MS Drug Shows Promising Results
11. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... ... May 23, 2017 , ... ... and Clinical Integration company, announced today that its iClinic V12.2 solution has achieved ... Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize team-based care with ...
(Date:5/23/2017)... ... May 23, 2017 , ... New England Journal Of Medicine Confirms Viability ... Policy Response”, -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price ... Sepsis ( http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, ...
(Date:5/23/2017)... ... May 23, 2017 , ... By all indications, and due ... County. While officials call for diligence, asking homeowners to scout for any open water ... concerns. Along with the annoying buzz of mosquitos is the buzz associated with potential ...
(Date:5/23/2017)... ... 2017 , ... Orbita’s Nathan Treloar will discuss the role of voice-powered healthcare ... Connected Health and IoT: Technology Innovators and Disruption , the workshop is part ... market research and consulting firm specializing in emerging consumer technology products and services. , ...
(Date:5/22/2017)... ... May 22, 2017 , ... The ... the scientific development, healthcare training and clinical application of medical infrared imaging, has ... to perform medical thermal imaging services. , The first new educational offering is ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, ... provides technology solutions to improve the clinical effectiveness ... results for the first quarter ended March 31, ... products enable our customers to identify when preventive ... intervene before events like heart attacks or strokes ...
(Date:5/6/2017)... --  Provista , a proven leader in the supply chain ... Jim Cunniff as the company,s new president and ... to Provista, including most recently serving as the president and ... . He assumed his new role with Provista on May ... Provista," says Jody Hatcher , president, Sourcing and Collaboration ...
(Date:5/4/2017)... Inc. (" Fortuna "), a private, clinical-stage biotech company, ... for embryonic and fetal stem cells by using direct reprogramming ... announced today the launch of its Scientific Advisory ... Father Kevin FitzGerald , S.J., PhD; Col. (R) ... , PhD. "We are excited and honored to ...
Breaking Medicine Technology: